Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views
New Delhi / Mumbai, December 15, 2025 — Corona Remedies Limited, the Ahmedabad-headquartered branded pharmaceutical formulations company, hit Dalal Street with a headline-worthy debut on Monday: the stock listed at a 38%+ premium to its IPO price, quickly becoming one of the most-watched new names in India’s healthcare space. Business Standard+2Moneycontrol+2